 |
|
Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder
Woo-Young Jung, Sae-Heon Jang, Sung-Gon Kim, Young-Myo Jae, Bo-Geum Kong, Ho-Chan Kim, Byeong-Moo Choe, Jeong-Gee Kim, Choong-Rak Kim
Psychiatry Investig. 2016;13(4):440-446. Published online 2016 Jul 25 DOI: https://doi.org/10.4306/pi.2016.13.4.440
|
|
Pharmacogenomics to support mental health medication therapy management: Clinical practice considerations and a conceptual framework to enhance patient care
Jeffrey R. Bishop, Mark E. Schneiderhan, Tiana Butler, Rachel M. Carpentier, Katharine R. Heins, Christine M. Formea
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.2024; 7(2): 160. CrossRef Antidepressant use and treatment-emergent sexual dysfunction among patients with major depressive disorder: Results from an internet-based survey study
Judith J. Stephenson, Maelys Touya, Lambros Chrones, Shivani A. Pandya, Chia-Chen Teng, Anita H. Clayton
Journal of Affective Disorders Reports.2024; 16: 100750. CrossRef The effect of adherence therapy on medication adherence, health beliefs, self‐efficacy, and depressive symptoms among patients diagnosed with major depressive disorder
Anas Husam Khalifeh, Fadwa Naji Alhalaiqa, Shaher Hamad Hamaideh, Robert Horne, Ayman Mohammad Hamdan‐Mansour
International Journal of Mental Health Nursing.2023; 32(3): 778. CrossRef “Heads Up” for Creatine Supplementation and its Potential Applications for Brain Health and Function
Darren G. Candow, Scott C. Forbes, Sergej M. Ostojic, Konstantinos Prokopidis, Matt S. Stock, Kylie K. Harmon, Paul Faulkner
Sports Medicine.2023; 53(S1): 49. CrossRef Program of algorithm for pharmacological treatment of major depressive disorder in China: Benefits or not?
Yuncheng Zhu, Fang Wang, Fan Wang, Hongmei Liu, Xiaoyun Guo, Zuowei Wang, Ruoqiao He, Xiaohui Wu, Lan Cao, Zhiguo Wu, Daihui Peng, Yiru Fang
Heliyon.2023; 9(11): e20951. CrossRef Prevalence, median time, and associated factors with the likelihood of initial antidepressant change: a cross-sectional study in Qatar
Nervana Elbakary, Sami Ouanes, Sadaf Riaz, Oraib Abdallah, Islam Mahran, Noriya Al-Khuzaei, Yassin Eltorki
BMC Psychiatry.2021;[Epub] CrossRef Switches and early discontinuations of antidepressant medication in young adults with depression
Pasi Lampela, Antti Tanskanen, Markku Lähteenvuo, Jari Tiihonen, Heidi Taipale
Journal of Affective Disorders.2021; 295: 1474. CrossRef Pharmacogenomics: A road ahead for precision medicine in psychiatry
Antonio F. Pardiñas, Michael J. Owen, James T.R. Walters
Neuron.2021; 109(24): 3914. CrossRef Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe?
Jennifer Severe, John F. Greden, Priyanka Reddy
FOCUS.2020; 18(2): 120. CrossRef Using the quantitative EEG method in predicting the response to treatment of affective disorders
S. A. Galkin, S. N. Vasilieva, G. G. Simutkin, G. D. Tkacheva, T. A. Oshkina, S. A. Ivanova, N. A. Bokhan
V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY.2020; (4): 26. CrossRef Integrating Patients’ Expectations into the Management of Their Depression: Report of a Symposium at the European College of Neuropsychopharmacology Congress
Koen Demyttenaere, Ellen Frank, David Castle, Elif Cindik-Herbrüggen
Advances in Therapy.2019; 36(S3): 73. CrossRef Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis
Geneviève Gauthier, Annie Guérin, Maryia Zhdanava, William Jacobson, George Nomikos, Elizabeth Merikle, Clément François, Vanessa Perez
BMC Psychiatry.2017;[Epub] CrossRef
|